K-Beauty Leader Dr.Althea Hits 35 Million Global Sales for 345 Relief Cream, Unveils Expanded 345 Relief Line

NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Dr.Althea, a leading Korean dermatology-inspired skincare brand, today announced a major global milestone: its cult-favorite 345 Relief Cream has officially surpassed 35 million units in cumulative sales worldwide. This landmark achievement underscores the product's immense global popularity and the deep consumer trust Dr.Althea has cultivated by delivering effective, science-backed solutions for sensitive and compromised skin. Powered by the soothing proprietary 345 Relief Complex™, the cream provides targeted relief for blemish-prone and sensitive skin.

"Surpassing 35 million units sold of our 345 Relief Cream is a proud moment for Dr.Althea and a testament to the trust our global community places in our formulations," said Dong Hoon Lee, CEO of Dr.Althea. "Driven by strong consumer demand, we are expanding our 345 Relief Line across broader daily skincare routines to support the evolving needs of sensitive skin worldwide."

Dr.Althea 345 Relief Line: Gentle Soothing Skincare for Sensitive, Blemish-prone Skin

Building on the success of the 345 Relief cream, 345 Relief Line offers a soothing skincare routine designed to support and maintain a healthy-looking complexion. The lineup includes:

• 345 Relief Cream: The globally beloved, cult-favorite moisturizer powered by the proprietary 345 Relief Complex™, combining three blemish-care, four nourishing, and five soothing ingredients to provide hydration and barrier support for blemish-prone and sensitive skin.
• 345 Relief Serum: A lightweight, hydrating serum formulated with 10,000 ppm Panthenol and 10,000 ppm Niacinamide. Designed for daily use, it delivers soothing moisture, replenishes hydration, and supports a balanced, healthy-looking complexion.
• 345 Relief Cream Mist: A hydrating mist formulated with 60% rice bran water and 10,000 ppm Panthenol to deliver an instant boost of soothing care. Its dual-layer formula combines a refreshing toner with a nourishing cream layer, providing long-lasting hydration that is especially ideal for dry and cold seasons.
• 345 Relief Cream Mask: A concentrated treatment mask with 30% Tea Tree Leaf Water, combining Resveratrol, Pantothenic Acid, and Niacinamide for skin-repairing care, Beta Glucan, Lotus PDRN, and Ceramide NP for nourishment, and Green Tea Leaf Water, Centella Leaf Water, Madecassoside, and Centella PDRN for soothing care.
• 345 Relief Spot Powder: A dual-layer spot treatment for blemish-prone areas, featuring 15% calamine powder and a soothing essence. It combines three sebum-control ingredients, four skin-barrier ceramides, and five soothing botanical extracts, alongside AHA, BHA, and PHA for gentle, skin-refining exfoliation.
• 345 Relief Milky Cleansing Oil: The newest addition to the 345 Relief Line, this PEG-free cleansing oil rapidly emulsifies to melt away makeup, impurities, and blackheads with minimal friction. Powered by a unique 3•4•5 Biome Cleansing System, it features three skin-refining ferments, four nourishing oils, and five pore-clearing ingredients to protect the skin barrier during cleansing.

As Dr.Althea's global footprint continues to expand, the brand remains dedicated to making premium Korean skincare easily accessible to its growing international community. Consumers in the US can now seamlessly discover and purchase the 345 Relief Line and other Dr.Althea favorites through major retail partners, including Amazon, Ulta Beauty, and Olive Young nationwide.

About Dr.Althea

Founded in 2014, Dr.Althea is a Korean dermatology-inspired skincare brand focused on long-term skin recovery and compromised skin barriers. Blending advanced dermatology with high-performance ingredients, all products are formulated for sensitive skin. Dr.Althea is widely recognized for its hero product, 345 Relief Cream, which has surpassed 35 million units sold worldwide with its soothing, fungal acne-safe, blemish-care, and barrier-repairing formula. Dr.Althea
has received prestigious recognition from major beauty awards, including the Allure Best of the Beauty Awards 2025, and the Marie Claire US Beauty Awards 2026.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

K-Beauty Leader Dr.Althea Hits 35 Million Global Sales for 345 Relief Cream, Unveils Expanded 345 Relief Line

ADH-5-13 joins the deployment-focused UDH-3-7 and a portfolio of two-, three- and five-finger robotic end effectors

PITTSBURGH, Sept. 30, 2026 /PRNewswire/ -- DH-Robotics today debuted the ADH-5-13, a five-finger dexterous hand with 13 independently controllable active degrees of freedom (DOF), at IROS 2026 in Pittsburgh. The company also demonstrated the UDH-3-7, its three-finger direct-drive dexterous hand, alongside a portfolio of two-, three- and five-finger end effectors for a range of gripping and manipulation tasks.

The debut reflects DH-Robotics' "Dexterity as Productivity" approach: matching hand architecture, sensing and control to the manipulation requirements of embodied AI research, teleoperation and robotic systems.

ADH-5-13: a five-finger platform for multi-finger manipulation

The ADH-5-13 uses an anthropomorphic five-finger configuration with 13 active DOF. The thumb, index finger and middle finger each have three DOF; the ring and little fingers each have two. The index and middle fingers also provide ±15° of lateral motion for a broader range of multi-finger poses.

At 735 g, the hand is designed to balance dexterity with system weight. DH-Robotics specifies a maximum lifting payload of up to 20 kg once an object is grasped.

The ADH-5-13 integrates fingertip tactile sensing and can accommodate additional sensing options, including electronic skin, six-axis force/torque sensors and vision-based tactile sensors. Sensors and individual modules can be replaced without dismantling the entire hand or a full finger, simplifying service and maintenance. According to DH-Robotics, this serviceable design improves maintenance efficiency by 300%, helping reduce downtime and operating and maintenance costs.

The hand's fully direct-drive, backdrivable architecture provides independent control of all 13 active DOF. Dual magnetic encoders at each joint provide position feedback, and DH-Robotics specifies fingertip positioning repeatability of ±0.2 mm. The company says the architecture supports hybrid force/position control and compliant contact behavior in manipulation tasks.

UDH-3-7: strength, flexibility and a compact three-finger form factor

The UDH-3-7 is built around a streamlined three-finger configuration with seven active DOF. DH-Robotics specifies a maximum payload of 15 kg, maximum fingertip force of 50 N, positioning repeatability of ±0.02 mm and a design life of one million cycles.

The hand also uses a direct-drive, backdrivable design. Its thumb supports a 180° range of rotation and opposition, enabling different grasp configurations for objects with varied shapes and materials.

UDH-3-7 supports CAN FD, RS-485 and EtherCAT. Development tools support C++ and Python, while ROS 2 integration and workflows using Isaac and MuJoCo can help teams evaluate and integrate the hand in embodied AI systems.

A portfolio organized around the task

DH-Robotics positions its two-, three- and five-finger end effectors around distinct manipulation needs:

•  Two-finger end effectors: general-purpose gripping and grasping.
•  Three-finger dexterous hands: a balance of strength, dexterity and working space for manipulation.
•  Five-finger dexterous hands: coordinated multi-finger manipulation and more complex dexterous tasks.

IROS attendees can see the portfolio at Booth #1008 through Sept. 30. The IROS 2026 conference runs Sept. 27–Oct. 1 in Pittsburgh.

About DH-Robotics

DH-Robotics develops robotic end effectors and precision motion-control components for industrial automation and embodied AI. Its portfolio includes electric grippers, dexterous hands, linear coil actuators, rotary grippers and servo electric cylinders. Learn more: https://en.dh-robotics.com/.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

DH-Robotics Debuts 13-DOF Direct-Drive Dexterous Hand at IROS 2026